Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
SI-BONE Inc
SIBN
$838M
| $2.44M | ﹤0.01% |
81,773
-59,937
| -42% | -$1.46M |
|
4802
PUT
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$330M
| $2.44M | ﹤0.01% |
6,252
-2,696
| -30% | -$1.28M |
|
4803
Direxion Daily Small Cap Bear 3x ETF
TZA
$209M
| $2.44M | ﹤0.01% |
4,449
-1,215
| -21% | -$1.04M |
|
4804
ProShares UltraPro S&P 500
UPRO
$5.7B
| $2.44M | ﹤0.01% |
63,610
-131,382
| -67% | -$4.32M |
|
4805
Ennis
EBF
$565M
| $2.44M | ﹤0.01% |
136,878
+26,189
| +24% | +$441K |
|
|
INFO
4806
CALL
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $2.44M | ﹤0.01% |
27,200
+800
| +3% | +$69.3K |
|
4807
PUT
Adaptive Biotechnologies
ADPT
$3.94B
| $2.44M | ﹤0.01% |
41,300
+20,900
| +102% | +$1.08M |
|
4808
CALL
W.P. Carey
WPC
$16.3B
| $2.44M | ﹤0.01% |
35,327
-8,678
| -20% | -$580K |
|
|
TGH
4809
DELISTED
Textainer Group Holdings limited
TGH
| $2.44M | ﹤0.01% |
127,352
+108,758
| +585% | +$1.86M |
|
4810
Idacorp
IDA
$8.18B
| $2.44M | ﹤0.01% |
25,416
-16,752
| -40% | -$1.53M |
|
4811
CALL
CNX Resources
CNX
$5.23B
| $2.44M | ﹤0.01% |
225,868
+42,068
| +23% | +$424K |
|
|
LOVE
4812
LoveSac
LOVE
$250M
| $2.44M | ﹤0.01% |
+56,592
| New | +$1.87M |
|
4813
CALL
Concentrix
CNXC
$1.42B
| $2.44M | ﹤0.01% |
+24,700
| New | +$2.47M |
|
4814
MGP Ingredients
MGPI
$383M
| $2.44M | ﹤0.01% |
51,790
+7,527
| +17% | +$324K |
|
|
ARNA
4815
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.44M | ﹤0.01% |
31,700
-16,000
| -34% | -$1.2M |
|
4816
CALL
Resideo Technologies
REZI
$3.13B
| $2.44M | ﹤0.01% |
114,556
+75,956
| +197% | +$1.22M |
|
4817
Alamo Group
ALG
$1.97B
| $2.43M | ﹤0.01% |
17,631
-11,503
| -39% | -$1.49M |
|
|
PMT
4818
CALL
PennyMac Mortgage Investment
PMT
$839M
| $2.43M | ﹤0.01% |
138,300
+45,300
| +49% | +$768K |
|
4819
Belden
BDC
$5.38B
| $2.43M | ﹤0.01% |
57,957
+4,259
| +8% | +$157K |
|
|
WPRT
4820
Westport Fuel Systems
WPRT
$33.2M
| $2.43M | ﹤0.01% |
45,515
+29,078
| +177% | +$914K |
|
|
ENLC
4821
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.43M | ﹤0.01% |
653,914
-552,195
| -46% | -$1.81M |
|
4822
PUT
Ichor Holdings
ICHR
$2.69B
| $2.42M | ﹤0.01% |
80,400
+36,500
| +83% | +$1.03M |
|
|
BPMC
4823
DELISTED
Blueprint Medicines
BPMC
| $2.42M | ﹤0.01% |
21,603
-48,188
| -69% | -$5.08M |
|
4824
CALL
Laureate Education
LAUR
$5.19B
| $2.42M | ﹤0.01% |
166,400
+121,600
| +271% | +$1.72M |
|
4825
PUT
ImmunityBio
IBRX
$8.39B
| $2.42M | ﹤0.01% |
181,700
+153,200
| +538% | +$1.47M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.